Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome

NCT04701164 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Guillain-Barre Syndrome

Interventions

DRUG: ANX005
DRUG: Placebo

Sponsor

Annexon, Inc.